Skip to main content

Penile Ultrasound

  • Chapter
  • First Online:
Ultrasound of the Male Genitalia

Abstract

Penile ultrasound is commonly used in the diagnostic workup of patients with erectile dysfunction (ED), but also plays an important role by providing an anatomic and functional assessment in a multitude of other conditions including Peyronie’s disease, priapism, penile fracture, penile urethral strictures, urethral stones, or diverticulae, or masses involving deep tissues of the penis. As a component of the evaluation for ED, penile Doppler ultrasound (PDU) is performed to assess the quality of arterial blood flow and sufficiency of veno-occlusive mechanisms, both necessary for adequate erections. More recently, PDU is playing a central role in the early detection of otherwise silent coronary artery disease (CAD) in men presented with ED as their initial symptom. PDU is also an essential component of the assessment of external genitalia in trauma situations. Penile ultrasound provides a readily available, minimally invasive diagnostic modality that evaluates both the structural anatomy and functional hemodynamics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Doubilet PM, et al. The penis. Semin Ultrasound CT MR. 1991;12(2):157–75.

    CAS  PubMed  Google Scholar 

  2. http://www.auanet.org/content/guidelines-and-quality-care/policy-statements.cfm.

  3. Shin D, Pregenzer G Jr, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19(1):5–11.

    Article  PubMed  Google Scholar 

  4. Tomada N, et al. Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. J Sex Med.

    Google Scholar 

  5. Corona G, et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med. 2010;7(5):1918–27.

    Article  PubMed  Google Scholar 

  6. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.

    CAS  PubMed  Google Scholar 

  7. Hayashi T, et al. Lifestyle intervention, behavioral changes, and improvement in cardiovascular risk profiles in the California WISEWOMAN project. J Womens Health (Larchmt). 2010;19(6):1129–38.

    Article  Google Scholar 

  8. Miner MM Erectile dysfunction: a harbinger or consequence: does its detection lead to a “Window of Curability?” J Androl.

    Google Scholar 

  9. Inman BA, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108–13.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Billups KL, et al. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res. 2008;20(3):236–42.

    Article  CAS  PubMed  Google Scholar 

  11. Patel U, Lees WR. Penile sonography. In: Solibiati L, Rizzatto G, Editors. Ultrasound of superficial structures. London: Churchill Livingstone; 1995. pp. 229–42.

    Google Scholar 

  12. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol. 2003;58(7):514–23.

    Article  CAS  PubMed  Google Scholar 

  13. Kim SH, et al. Doppler sonography of deep cavernosal artery of the penis: variation of peak systolic velocity according to sampling location. J Ultrasound Med. 1994;13(8):591–4.

    CAS  PubMed  Google Scholar 

  14. Roy C, et al. Duplex Doppler sonography of the flaccid penis: potential role in the evaluation of impotence. J Clin Ultrasound. 2000;28(6):290–4.

    Article  CAS  PubMed  Google Scholar 

  15. Mancini M, et al. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl. 2000;23(4):199–204.

    Article  CAS  PubMed  Google Scholar 

  16. van Ahlen H, et al. Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol. 1994;151(5):1227–30.

    PubMed  Google Scholar 

  17. Patel U, et al. Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies. Clin Radiol. 1993;48(1):18–24.

    Article  CAS  PubMed  Google Scholar 

  18. Broderick GA, Lue TF. The penile blood flow study: evaluation of vasculogenic impotence. In: Jonas U, Thon WF, Stief CG, Editors. Erectile dysfunction. Berlin: Springer; 1991.

    Google Scholar 

  19. Shabsigh R, et al. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol. 1990;143(5):924–7.

    CAS  PubMed  Google Scholar 

  20. Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol. 1989;153(6):1149–53.

    Article  CAS  PubMed  Google Scholar 

  21. Lue TF, et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155(3):777–81.

    Article  CAS  PubMed  Google Scholar 

  22. Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin North Am. 1988;15(1):65–76.

    CAS  PubMed  Google Scholar 

  23. Pescatori ES, et al. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol. 1994;151(5):1209–16.

    CAS  PubMed  Google Scholar 

  24. Benson CB, Aruny JE, Vickers MA Jr. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. AJR Am J Roentgenol. 1993;160(1):71–3.

    Article  CAS  PubMed  Google Scholar 

  25. Bassiouny HS, Levine LA. Penile duplex sonography in the diagnosis of venogenic impotence. J Vasc Surg. 1991;13(1):75–82. (discussion 82–3)

    Article  CAS  PubMed  Google Scholar 

  26. Quam JP, et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR Am J Roentgenol. 1989;153(6):1141–7.

    Article  CAS  PubMed  Google Scholar 

  27. Naroda T, et al. Clinical studies for venogenic impotence with color Doppler ultrasonography-evaluation of resistance index of the cavernous artery. Nippon Hinyokika Gakkai Zasshi. 1996;87(11):1231–5.

    CAS  PubMed  Google Scholar 

  28. Cormio L, et al. Resistance index as a prognostic factor for prolonged erection after penile dynamic colour Doppler ultrasonography. Eur Urol. 1998;33(1):94–7.

    Article  CAS  PubMed  Google Scholar 

  29. Feldman HA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000;30(4):328–38.

    Article  CAS  PubMed  Google Scholar 

  30. Blumentals WA, et al. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res. 2004;16(4):350–3.

    Article  CAS  PubMed  Google Scholar 

  31. Sullivan ME, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res. 1999;43(3):658–65.

    Article  CAS  PubMed  Google Scholar 

  32. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89(3):251–3.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur Urol. 2003;44(3):352–4.

    Article  PubMed  Google Scholar 

  34. Guay AT. The emerging link between hypogonadism and metabolic syndrome. J Androl. 2009;30(4):370–6.

    Article  CAS  PubMed  Google Scholar 

  35. Traish AM, Guay AT Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med. 2006;3(3):382–404. (discussion 404–7)

    Article  CAS  PubMed  Google Scholar 

  36. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137(5):829–36.

    CAS  PubMed  Google Scholar 

  37. O’Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract. 2001;55(3):219–20.

    PubMed  Google Scholar 

  38. Mulhall J, Teloken P, Barnas J. Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography. J Sex Med. 2009;6(3):820–5.

    Article  PubMed  Google Scholar 

  39. Zambon JP, et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-control study. Sao Paulo Med J. 2010;128(3):137–40.

    Article  PubMed  Google Scholar 

  40. Mottillo S, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

    Article  PubMed  Google Scholar 

  41. Bohm M, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation. 121(12):1439–46.

    Google Scholar 

  42. Batty GD, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol. 2010;56(23):1908–13.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Kang BC, et al. Post-traumatic arterial priapism: colour Doppler examination and superselective arterial embolization. Clin Radiol. 1998;53(11):830–4.

    Article  CAS  PubMed  Google Scholar 

  44. Asgari MA, et al. Penile fractures: evaluation, therapeutic approaches and long-term results. J Urol. 1996;155(1):148–9.

    Article  CAS  PubMed  Google Scholar 

  45. El-Bahnasawy MS, Gomha MA. Penile fractures: the successful outcome of immediate surgical intervention. Int J Impot Res. 2000;12(5):273–7.

    Article  CAS  PubMed  Google Scholar 

  46. Atan A, et al. Idiopathic penile mondors’ disease: a case report. Int Urol Nephrol. 2002;34(1):97–9.

    Article  PubMed  Google Scholar 

  47. Dicuio M, et al. Doppler ultrasonography in a young patient with penile Mondor’s disease. Arch Ital Urol Androl. 2005;77(1):58–9.

    PubMed  Google Scholar 

  48. Sasso F, et al. Penile Mondors’ disease: an underestimated pathology. Br J Urol. 1996;77(5):729–32.

    Article  CAS  PubMed  Google Scholar 

  49. Nachmann MM, et al. Sickle cell episode manifesting as superficial thrombophlebitis of the penis. J Am Osteopath Assoc. 2003;103(2):102–4.

    PubMed  Google Scholar 

  50. Luzzi GA, Pattinson J, Wathen CG. Penile Mondor’s disease and inherited thrombophilia. Int J STD AIDS. 2006;17(1):70–1.

    Article  CAS  PubMed  Google Scholar 

  51. Brock G, et al. The anatomy of the tunica albuginea in the normal penis and Peyronie’s disease. J Urol. 1997;157(1):276–81.

    Article  CAS  PubMed  Google Scholar 

  52. Chou YH, et al. High-resolution real-time ultrasound in Peyronie’s disease. J Ultrasound Med. 1987;6(2):67–70.

    CAS  PubMed  Google Scholar 

  53. Kadioglu A, et al. Color Doppler ultrasound assessment of penile vascular system in men with Peyronie’s disease. Int J Impot Res. 2000;12(5):263–7.

    Article  CAS  PubMed  Google Scholar 

  54. Richards G, Goldenberg E, Pek H, Gilbert BR. Penile sonoelastography for the localization of a non-palpable, non-sonographically visualized lesion in a patient with penile curvature from peyronie’s disease. J Sex Med. 2013;11:5.

    Google Scholar 

  55. Horenblas S, et al. Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology. 1994;43(5):702–7.

    Article  CAS  PubMed  Google Scholar 

  56. Lont AP, et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 2003;91(6):493–5.

    Article  CAS  PubMed  Google Scholar 

  57. Lan SK, et al. Penile metastasis secondary to nasal NK/T-cell lymphoma. Urology. 2008;72(5):1014–5.

    Article  PubMed  Google Scholar 

  58. Gallentine ML, Morey AF. Imaging of the male urethra for stricture disease. Urol Clin North Am. 2002;29(2):361–72.

    Article  PubMed  Google Scholar 

  59. Morey AF, McAninch JW. Role of preoperative sonourethrography in bulbar urethral reconstruction. J Urol. 1997;158(4):1376–9.

    Article  CAS  PubMed  Google Scholar 

  60. Choudhary S, et al. A comparison of sonourethrography and retrograde urethrography in evaluation of anterior urethral strictures. Clin Radiol. 2004;59(8):736–42.

    Article  CAS  PubMed  Google Scholar 

  61. Morey AF, McAninch JW. Sonographic staging of anterior urethral strictures. J Urol. 2000;163(4):1070–5.

    Article  CAS  PubMed  Google Scholar 

  62. Kim B, Kawashima A, LeRoy AJ. Imaging of the male urethra. Semin Ultrasound CT MR. 2007;28(4):258–73.

    Article  PubMed  Google Scholar 

  63. Bearcroft PW, Berman LH. Sonography in the evaluation of the male anterior urethra. Clin Radiol. 1994;49(9):621–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soroush Rais-Bahrami MD .

Editor information

Editors and Affiliations

Appendix

Appendix

Patient Instructions for Penile Injection Therapy

I Preparation for Injection

Items You Will Need

  • Alcohol sponges or swaps

  • 1 mL insulin syringe with #28 or #30 gauge needle. These are disposable and not to be reused for a second injection. Disposal should be performed with the cap on the needle so as not to injure anyone disposing of trash.

  • Papaverine/Phentomlamine combination, Prostaglandin E1 or Papaverine/Phentolamine/Prostaglandin combination either pre-drawn by the physician a pharmacist in the syringe, or in a vial to be drawn into the syringe by the patient in the appropriate volume as prescribed by the physician. The medication must be refrigerated and away from light exposure.

Filling the Syringe

  1. 1.

    Check the expiration date of medication. Hold the medication bottle so that your fingers do not touch the rub or stopper.

figure b
  1. 2.

    Using a circular motion, wipe off the top of the bottle with alcohol swab.

figure c
  1. 3.

    Remove the needle cover. Do not allow the need of to touch anything before drawing the medication or before injecting the medication.

figure d
  1. 4.

    Draw an amount of the air is cool to the mountain medication to be injected into the syringe. Push the need of and to the center of the stopper. Push the air into the bottle.

figure e
  1. 5.

    Turn the bottle and syringe upside down. Solely draw the medication into the syringe. Tap the syringe gently to remove the bubbles.

figure f
  1. 6.

    Move the plunger in and out several times while gently tapping the syringe, just removing all air bubbles.

figure g
  1. 7.

    Gently removing the old from the bottle and replace the. The soon the protective and place the filled syringe within easy reach prior to injection.

figure h

II Self-injection Technique

Step 1

Grasp the head of the penis, not the skin, and hold upwards toward the trunk. Position the penis along your inner thigh. Choose the injection site on the side of the penis. Avoid injecting into any visible veins. The crossed hatched areas in the figure below represent the ideal locations to inject into.

figure i

Step 2

Wipe the skin with an alcohol swab.

figure j

Step 3

Pick up the syringe between the thumb and middle finger, like a pen, and push the needle gently but firmly through the skin until the entire need is buried inside the penis.

figure k

Step 4

Holding the syringe, use your thumb to slowly (8–10 s) inject the entire amount of medication. Then remove the needle with from your penis.

figure l

Step 5

Immediately apply pressure on the injection site with another alcohol wipe for at least 2 min. Make sure there is no bleeding.

figure m

Step 6

Dispose of the syringe unit into the puncture-proof receptacle provided.

Step 7

Stand up to allow your erection to develop quickly. You are now ready to start sexual foreplay. You will have a full or action within a few minutes.

Normally, the erection will last anywhere from 30–120 min. If your erection lasts longer than 3 h, you should seek immediate medical attention.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rais-Bahrami, S., Gilbert, B. (2015). Penile Ultrasound. In: Gilbert, B. (eds) Ultrasound of the Male Genitalia. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7744-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7744-0_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7743-3

  • Online ISBN: 978-1-4614-7744-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics